Research from Atrium Research, Atrium Research Corporation

Atrium Research

Atrium Research provides institutional quality issuer paid research on public equities in North America. Our investment philosophy takes a 3-5 year view on equities currently being overlooked by the market. Our research process emphasizes understanding the key performance metrics for each specific company, trustworthy management teams, unit economics, and an in-depth valuation analysis.

Our research product includes in-depth initiation reports, research notes, thematic research pieces, and company fact sheets.

Research from Atrium Research

Atrium Research Corporation

Atrium Research provides institutional quality issuer paid research on public equities in North America. Our investment philosophy takes a 3-5 year view on equities currently being overlooked by the market. Our research process emphasizes understanding the key performance metrics for each specific company, trustworthy management teams, unit economics, and an in-depth valuation analysis. 

Our research product includes in-depth initiation reports, research notes, thematic research pieces, and company fact sheets.

Equity Bottom-Up

<ul>
<li>DNG announced that it has signed a share purchase agreement to acquire 100% of the 1,500tpd permitted processing plant in Ecuador.</li>
<li>The total consideration for the plant is $25M (including $9.75M for the acquisition and $15.25M in capex).</li>
<li>The asset will produce 75Koz of gold, or $10M in OCF using our assumptions, representing 2.5x OCF.</li>
</ul>


DNG announced that it has signed a share purchase agreement to acquire 100% of the 1,500tpd permitted processing plant in Ecuador.
The total consideration for the plant is $25M (including $9.75M for the acquisition and $15.25M in capex).
The asset will produce 75Koz of gold, or $10M in OCF using our assumptions, representing 2.5x OCF.


DNG: Signs Purchase Agreement to Acquire Plant in Ecuador

Dynacor Group

DNG: Signs Purchase Agreement to Acquire Plant in Ecuador